Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSoftcat Regulatory News (SCT)

Share Price Information for Softcat (SCT)

Share Price is delayed by 15 minutes
Get Live Data
1,872.00    -8.00 (-0.43%)
Bid:
1,864.00
Ask:
1,867.00
Spread: 3.00 (0.161%)
Market Cap: £3.67b
SCT Live PriceLast checked at - London Stock Exchange

Intraday Softcat Share Chart

Share Buyback Programme

8 Jan 2026 07:00

RNS Number : 0707O
Softcat PLC
08 January 2026
 

8 January 2026

 

SOFTCAT plc

('Softcat', the 'Group')

 

Share buyback programme

Softcat plc (LSE: SCT.L), a leading UK provider of IT infrastructure products and services, today announces the commencement of a share buyback programme (the 'Programme') to repurchase ordinary shares of £0.0005 each (the 'Shares') for aggregate consideration of up to £45 million. The Programme commences today, 8 January 2026 and is expected to complete in the first half of the calendar year.

The Programme is consistent with the Group's disciplined capital allocation policy and reflects the Board's continued confidence in Softcat's long-term prospects, supported by the Group's strong cash generation and robust financial position.

Details of the Programme

Softcat has entered into a non-discretionary agreement with J.P. Morgan Securities plc ('J.P. Morgan') to conduct the buyback on its behalf and, acting as riskless principal, carry out on-market purchases of Shares (including, for the avoidance of doubt, in the case of any purchases made during closed periods). J.P. Morgan will simultaneously sell the repurchased Shares to Softcat for cancellation. Softcat will announce any market repurchase of Shares no later than 7.30 a.m. on the business day following the calendar day on which the repurchase occurred. 

Any purchases of Shares in relation to this announcement will be carried out on the London Stock Exchange in accordance with certain pre-set parameters outlined in the agreement with J.P. Morgan. These arrangements are in accordance with (and subject to the limits prescribed by) the Group's general authority to repurchase Shares granted by its shareholders at the annual general meeting ('AGM') held on 15 December 2025; Chapter 9 of the Financial Conduct Authority's UK Listing Rules; and applicable regulations, including those provisions of the Market Abuse Regulation (EU) No. 596/2014 (as incorporated into domestic law by the European Union (Withdrawal) Act 2018) and the Commission Delegated Regulation (EU) 2016/1052 (as incorporated into domestic law by the European Union (Withdrawal) Act 2018).

The maximum number of Shares which may currently be purchased or committed to be purchased by Softcat under the Programme is 19,994,626, which is the maximum number pursuant to the relevant authorities granted by shareholders at Softcat's latest AGM.

 

For further information, please contact:

 

 

 

Softcat plc:

+44 (0)1628 403 403

Graham Charlton, Chief Executive Officer

Katy Mecklenburgh, Chief Financial Officer

Michael Watts, Head of Investor Relations

FTI Consulting LLP:

+44 (0)20 3727 1000

Ed Bridges

Matt Dixon

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFLTLRIDIIR
Date   Source Headline
9th Feb 20183:28 pmRNSDirector/PDMR Shareholding
6th Feb 20187:00 amRNSPre Interim Results Trading Update
10th Jan 20182:12 pmRNSDirector/PDMR Shareholding
2nd Jan 20184:39 pmRNSDirector/PDMR Shareholding
12th Dec 20175:47 pmRNSHolding(s) in Company
12th Dec 20175:34 pmRNSHolding(s) in Company
11th Dec 201711:22 amRNSDirector/PDMR Shareholding
8th Dec 20174:21 pmRNSTotal Voting Rights
8th Dec 20174:21 pmRNSResult of AGM
30th Nov 20175:26 pmRNSDirector/PDMR Shareholding
30th Nov 20175:25 pmRNSDirector/PDMR Shareholding
29th Nov 20177:00 amRNSQ1 2018 Trading Update
16th Nov 20174:24 pmRNSReplacement - Director/PDMR Shareholding
16th Nov 20174:08 pmRNSDirector/PDMR Shareholding
15th Nov 20179:36 amRNSHolding(s) in Company
13th Nov 20177:00 amRNSGraeme Watt to be appointed as new CEO
9th Nov 20173:01 pmRNSDirector/PDMR Shareholding
3rd Nov 201712:09 pmRNSAnnual Financial Report
31st Oct 20177:00 amRNSAdditional Listing
18th Oct 20177:00 amRNSFinal Results
10th Oct 20173:04 pmRNSDirector/PDMR Shareholding
4th Oct 20174:33 pmRNSHolding(s) in Company
18th Sep 20179:00 amRNSNotice of Results
12th Sep 20172:23 pmRNSDirector/PDMR Shareholding
10th Aug 20174:24 pmRNSDirector/PDMR Shareholding
25th Jul 20173:23 pmRNSDirector/PDMR Shareholding
11th Jul 20174:31 pmRNSDirector/PDMR Shareholding
9th Jun 201711:08 amRNSDirector/PDMR Shareholding
26th May 20172:31 pmRNSHolding(s) in Company
24th May 20177:00 amRNSBoard Changes
24th May 20177:00 amRNSQ3 2017 Trading Update
11th May 20171:15 pmRNSDirector/PDMR Shareholding
8th May 20174:46 pmRNSHolding(s) in Company
28th Apr 201711:40 amRNSDirector/PDMR Shareholding
11th Apr 20174:30 pmRNSDirector/PDMR Shareholding
22nd Mar 20177:00 amRNSHalf-year Report
9th Mar 20172:45 pmRNSDirector/PDMR Shareholding
20th Feb 201710:00 amRNSNotice of Results
10th Feb 20179:57 amRNSDirector/PDMR Shareholding
12th Jan 20173:08 pmRNSDirector/PDMR Shareholding
4th Jan 20174:55 pmRNSDirectorate Change
13th Dec 201610:26 amRNSDirector/PDMR Shareholding
8th Dec 20165:42 pmRNSResult of AGM
8th Dec 20165:35 pmRNSDirector/PDMR Shareholding
23rd Nov 20167:00 amRNSQ1 2017 Trading Update
16th Nov 20165:52 pmRNSDirector/PDMR Shareholding
10th Nov 20169:21 amRNSDirector/PDMR Shareholding
9th Nov 20167:00 amRNSTotal Voting Rights
7th Nov 20167:00 amRNSAdditional Listing of Shares
2nd Nov 20162:58 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.